Wang, Mengmei E;
Hodge, Allison M;
Li, Sherly X;
Southey, Melissa C;
Giles, Graham G;
Dugué, Pierre-Antoine;
(2023)
Adiposity and plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation.
Obesity Research & Clinical Practice
, 17
(3)
pp. 203-209.
10.1016/j.orcp.2023.04.004.
Preview |
Text
Wang_Adiposity and plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation_AAM.pdf Download (592kB) | Preview |
Abstract
AIM: The kynurenine pathway is increasingly recognised to play a role in inflammation and disease. We assessed the cross-sectional and longitudinal associations of adiposity measures (body mass index, waist-hip ratio, waist circumference and fat mass ratio) with plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation. METHODS: We used data from 970 Melbourne Collaborative Cohort Study participants who had plasma markers measured at baseline (median age 59 years) and follow-up (median age 70 years). Linear regression was used to assess cross-sectional and longitudinal associations between four adiposity measures and concentrations of i) nine kynurenine pathway metabolites; ii) two derived markers; iii) eight traditional inflammatory markers. RESULTS: Cross-sectionally, most kynurenine metabolites were strongly associated with adiposity measures at both time points; associations were generally stronger than for most inflammation markers except CRP (e.g. body mass index at baseline, quinolinic acid (per S.D. β = 0.30, 95%CI: 0.24–0.36, P = 10−21), kynurenine (β = 0.25, 95%CI: 0.19–0.31, P = 10−16) and CRP (β = 0.31, 95%CI: 0.25–0.37, P = 10−24), and remained largely unchanged after adjustment for confounders. Longitudinally, changes in adiposity measures over approximately a decade were positively associated with changes in kynurenine metabolite concentrations (in particular for 3-hydroxyanthranilic acid, kynurenine and quinolinic acid), and more strongly so than for other markers of inflammation, including CRP. CONCLUSIONS: In middle-aged and older adults, plasma concentrations of kynurenine metabolites are strongly associated with adiposity, both cross-sectionally and longitudinally. Our study demonstrates that kynurenine metabolites may be valuable markers to monitor the adverse consequences of obesity.
Type: | Article |
---|---|
Title: | Adiposity and plasma concentrations of kynurenine pathway metabolites and traditional markers of inflammation |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.orcp.2023.04.004 |
Publisher version: | https://doi.org/10.1016/j.orcp.2023.04.004 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher's terms and conditions. |
Keywords: | Inflammation, Tryptophan kynurenine pathway, Body composition, Body size, Aging |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Epidemiology and Health |
URI: | https://discovery.ucl.ac.uk/id/eprint/10179101 |
Archive Staff Only
View Item |